To evaluate the effectiveness of serum biomarkers and CT-derived muscle indices in identifying sarcopenia related to pancreatic neoplasm.
Comparative clinical study design
Assessment of circulating biomarkers
Evaluation of CT-derived muscle indices
Identification of sarcopenia improved with combined use of biomarkers and muscle indices
Clinical relevance established for pancreatic cancer diagnosis
Resumen
The combined use of circulating biomarkers and CT-derived muscle indices provides a clinically relevant approach for identifying sarcopenia in pancreatic cancer.